Abiopharma

Westlake Corporation Declares Quarterly Dividend

Health Catalyst to Participate in Upcoming Investor Conferences

Evolus - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Coherent Introduces Axon FP – A Breakthrough Fiber-Delivered Femtosecond Laser for Multiphoton Microscopy

4DMT Announces New Employment Inducement Grants

Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates

Biogen Completes Acquisition of Alcyone Therapeutics